• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

hepatocellular carcinoma (HCC) - Articles and news items

red-pill

RedHill Biopharma commences Phase II hepatocellular carcinoma study

Industry news / 5 October 2016 / Niamh Louise Marriott, Digital Content Producer

RedHill Biopharma, will shortly commence a study evaluating yeliva (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), pending final…

regorafenib

Regorafenib increases overall survival in hepatocellular carcinoma study

Industry news / 29 June 2016 / Victoria White, Digital Content Producer

Results from the Phase III RESORCE trial investigating Bayer’s regorafenib in patients with unresectable hepatocellular carcinoma have been announced…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +